<document id="DDI-DrugBank.d531">
    <sentence id="DDI-DrugBank.d531.s29" text="In uninfected volunteers, 46% developed rash while receiving SUSTIVA and clarithromycin.">
        <entity charOffset="61-67" id="DDI-DrugBank.d531.s29.e0" text="SUSTIVA" type="brand" />
        <entity charOffset="73-86" id="DDI-DrugBank.d531.s29.e1" text="clarithromycin" type="drug" />
        <pair ddi="true" e1="DDI-DrugBank.d531.s29.e0" e2="DDI-DrugBank.d531.s29.e1" id="DDI-DrugBank.d531.s29.p0" type="effect" />
    </sentence>
    <sentence id="DDI-DrugBank.d531.s63" text="Monitoring of liver enzymes is recommended when SUSTIVA is used in combination with ritonavir.">
        <entity charOffset="48-54" id="DDI-DrugBank.d531.s63.e0" text="SUSTIVA" type="brand" />
        <entity charOffset="84-92" id="DDI-DrugBank.d531.s63.e1" text="ritonavir" type="drug" />
        <pair ddi="true" e1="DDI-DrugBank.d531.s63.e0" e2="DDI-DrugBank.d531.s63.e1" id="DDI-DrugBank.d531.s63.p0" type="advise" />
    </sentence>
    <sentence id="DDI-DrugBank.d531.s75" text="Potential for reduction in anticonvulsant and/or efavirenz plasma levels;">
        <entity charOffset="27-40" id="DDI-DrugBank.d531.s75.e0" text="anticonvulsant" type="group" />
        <entity charOffset="49-57" id="DDI-DrugBank.d531.s75.e1" text="efavirenz" type="drug" />
        <pair ddi="true" e1="DDI-DrugBank.d531.s75.e0" e2="DDI-DrugBank.d531.s75.e1" id="DDI-DrugBank.d531.s75.p0" type="mechanism" />
    </sentence>
    </document>